BIOTON S.A. Stock Price

WSE:BIO Community·zł356.3m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

BIO Share Price Performance

zł0

-3.15 (-100.00%)

zł0

-3.15 (-100.00%)

zł0

Mon, 17 Nov 25

Share Pricen/a

BIO Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

2 Risks

0 Rewards

View Full Analysis

BIOTON S.A. Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: -0.033
: 29.69%
: -0.95%
: 4.4%

View Full Analysis

About BIO

Founded: 1989
Employees: 363
CEO: Jeremy Launders
WebsiteView website: www.bioton.pl

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.